Cryopreservation for stem cells & cell therapies

Cryopreservation of stem cells and cell therapies for modern regenerative medicine, cell and gene therapies, and ATMPs. Consarctic offers highly secure cryo-infrastructures for research, biotechnology, cell therapy manufacturers, and clinical applications.
GMP-compliant cryogenic storage down to −196°C (LN₂)
Maximum safety for stem cells & cell therapies
Automated systems for research & industry

Safe, GMP-compliant long-term storage with Consarctic

The long-term storage of sensitive biological samples requires more than just low-temperature technology. Validated processes, redundant systems, and continuous monitoring are crucial. Consarctic develops comprehensive cryopreservation solutions for stem cells and cell therapies that meet the highest GMP requirements and offer maximum process reliability.

1,500+ satisfied customers

Why Consarctic offers the ideal cryo-infrastructure for stem cells & cell therapies

Cell therapy products are highly sensitive, valuable, and subject to stringent regulatory requirements. Consarctic combines technological excellence, GMP expertise, and decades of experience in developing safe cryopreservation solutions.

Maximum cell viability through stable cryo-conditions
GMP-compliant planning, validation & documentation
Automated LN₂ supply with real-time monitoring
Maximum operational reliability through redundant systems

Overview of Consarctic solutions for stem cell and cell therapy storage

Consarctic offers modular, scalable cryopreservation solutions that can be flexibly adapted to growing production capacities and new therapeutic approaches. Whether for research laboratories, biotech companies, or industrial cell therapy production – our systems are designed for the future.

Fully automated LN₂ supply & GMP-compliant cryogenic storage systems

Cryostorage systems combine automated nitrogen supply, intelligent control, and validated hardware into a seamless GMP infrastructure. The result: reproducible processes, minimized operating costs, and maximum safety for sensitive cell therapies.

FAQ

Frequently asked questions about cryopreservation of stem cells & cell therapies

Why is a specialized infrastructure for cell therapies essential?

Cell therapies are extremely sensitive to temperature fluctuations and process errors. A specialized infrastructure ensures that cell quality and regulatory compliance are guaranteed at all times.

How is cell viability maintained over decades?

Stable cryogenic temperatures, controlled freezing processes and continuous monitoring allow cells to be stored for decades without loss of quality.

What are the advantages of a single-source LN₂ automation solution?

An integrated solution significantly reduces interfaces, minimizes sources of error, and simplifies validation, operation, and maintenance.

What GMP requirements apply to the cryostorage of ATMPs?

Storage must be validated, documented, monitored, and traceable. This includes qualified systems, alarm scenarios, emergency plans, and regular re-validations.

Which monitoring systems are recommended for cell therapy storage?

Redundant temperature and level sensors, real-time monitoring, automated alarms, and auditable data storage are recommended.

contact us

Speak to our experts on GMP-compliant cell therapy storage

Are you planning a new cryo-infrastructure or would you like to expand existing systems in compliance with GMP? The experts at Consarctic will advise you individually – from the concept phase to the long-term operation of your cryopreservation solution for stem cells and cell therapies.

Thank you! Your form has been received!
Oops! Something went wrong while submitting the form.